These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11197048)

  • 1. Non-steroidal anti-inflammatory drugs with different cyclooxygenase inhibitory profiles that prevent aberrant crypt foci formation but vary in acute gastrotoxicity in a rat model.
    Brown WA; Skinner SA; Malcontenti-Wilson C; Misajon A; DeJong T; Vogiagis D; O'Brien PE
    J Gastroenterol Hepatol; 2000 Dec; 15(12):1386-92. PubMed ID: 11197048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferation.
    Brown WA; Skinner SA; Malcontenti-Wilson C; Vogiagis D; O'Brien PE
    Gut; 2001 May; 48(5):660-6. PubMed ID: 11302965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the effects of COX and non-COX-inhibiting NSAIDs on enhancement of apoptosis and inhibition of aberrant crypt foci formation in a rat colorectal cancer model.
    Martin JE; Young GP; LE Leu RK; Hu Y
    Anticancer Res; 2013 Sep; 33(9):3581-8. PubMed ID: 24023283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulindac and indomethacin inhibit formation of aberrant crypt foci in the colons of dimethyl hydrazine treated rats.
    Charalambous D; Farmer C; O'Brien PE
    J Gastroenterol Hepatol; 1996 Jan; 11(1):88-92. PubMed ID: 8672749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.
    Reddy BS; Rao CV; Seibert K
    Cancer Res; 1996 Oct; 56(20):4566-9. PubMed ID: 8840961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-steroidal anti-inflammatory agents with selective inhibitory activity on cyclooxygenase-2. Interest and future prospects].
    Blain H; Jouzeau JY; Netter P; Jeandel C
    Rev Med Interne; 2000 Nov; 21(11):978-88. PubMed ID: 11109595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase?
    Alberts DS; Hixson L; Ahnen D; Bogert C; Einspahr J; Paranka N; Brendel K; Gross PH; Pamukcu R; Burt RW
    J Cell Biochem Suppl; 1995; 22():18-23. PubMed ID: 8538196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of arylamine-induced colorectal aberrant crypts.
    Feng Y; Neale JR; Doll MA; Hein DW
    Exp Biol Med (Maywood); 2008 Jan; 233(1):71-5. PubMed ID: 18156308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat colorectal tumours treated with a range of non-steroidal anti-inflammatory drugs show altered cyclooxygenase-2 and cyclooxygenase-1 splice variant mRNA expression levels.
    Vogiagis D; Brown W; Glare EM; O'Brien PE
    Carcinogenesis; 2001 Jun; 22(6):869-74. PubMed ID: 11375891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats.
    Tachibana M; Inoue N; Yoshida E; Matsui M; Ukai Y; Yano J
    Pharmacology; 2003 Jun; 68(2):96-104. PubMed ID: 12711837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2.
    Wallace JL; McKnight W; Reuter BK; Vergnolle N
    Gastroenterology; 2000 Sep; 119(3):706-14. PubMed ID: 10982765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemopreventive effects of nonsteroidal anti-inflammatory drugs on 1,2-dimethylhydrazine-induced colon carcinogenesis in rats.
    Kanwar SS; Vaiphei K; Nehru B; Sanyal SN
    Toxicol Mech Methods; 2007; 17(4):197-204. PubMed ID: 20020969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemopreventive effect of N-(2-cyclohexyloxy-4-nitrophenyl)methane sulfonamide (NS-398), a selective cyclooxygenase-2 inhibitor, in rat colon carcinogenesis induced by azoxymethane.
    Yoshimi N; Shimizu M; Matsunaga K; Yamada Y; Fujii K; Hara A; Mori H
    Jpn J Cancer Res; 1999 Apr; 90(4):406-12. PubMed ID: 10363578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin: a novel target for indomethacin-induced gastric injury.
    Chiou SK; Tanigawa T; Akahoshi T; Abdelkarim B; Jones MK; Tarnawski AS
    Gastroenterology; 2005 Jan; 128(1):63-73. PubMed ID: 15633124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal anti-inflammatory drugs, COX-2 and colorectal cancer.
    Patrignani P
    Toxicol Lett; 2000 Mar; 112-113():493-8. PubMed ID: 10720771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemopreventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on 1, 2-dimethylhydrazine-induced rat colon carcinogenesis.
    Wei M; Morimura K; Wanibuchi H; Shen J; Doi K; Mitsuhashi M; Moku M; Salim EI; Fukushima S
    Cancer Lett; 2003 Dec; 202(1):11-6. PubMed ID: 14643021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemopreventive response of diclofenac, a non-steroidal anti-inflammatory drug in experimental carcinogenesis.
    Kaur Saini M; Kaur J; Sharma P; Nath Sanyal S
    Nutr Hosp; 2009; 24(6):717-23. PubMed ID: 20049376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM; Lindley C
    Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.